Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Hamilton Hm 11
- Most recent report
- 6-K, filed Aug 29, 2025
- Filings on record
- 518 filings
- On EDGAR
- CIK 1601936
- Fiscal year ends
- December
- Filer status
- Non-accelerated filer
Financials 8 of 171
- 6-K Report a foreign issuer made public elsewhere Aug 29, 2025
- 6-K Report a foreign issuer made public elsewhere Jun 11, 2025
- 6-K Report a foreign issuer made public elsewhere May 9, 2025
- 20-F Annual report, foreign issuer Apr 30, 2025
- 6-K Report a foreign issuer made public elsewhere Apr 30, 2025
- 6-K Report a foreign issuer made public elsewhere Mar 10, 2025
- 6-K Report a foreign issuer made public elsewhere Dec 20, 2024
- 6-K Report a foreign issuer made public elsewhere Oct 4, 2024
Prospectuses and Registrations 8 of 130
- 25-NSE Notice that a security was delisted Jun 17, 2025
- S-8 Registration statement for an employee plan Apr 4, 2025
- 424B4 Final prospectus for an offering Sep 18, 2024
- F-1 Registration statement, foreign issuer Aug 22, 2024
- POS AM Post-effective amendment to a registration Jul 8, 2024
- 424B4 Final prospectus for an offering Apr 17, 2024
- S-8 Registration statement for an employee plan Apr 10, 2024
- F-1 Registration statement, foreign issuer Apr 10, 2024
Ownership 8 of 54
- SCHEDULE 13G/A Large holder reported a passive stake, amended May 15, 2025
- SCHEDULE 13D/A Large holder reported an active stake, amended May 6, 2025
- SCHEDULE 13G/A Large holder reported a passive stake, amended Feb 14, 2025
- SC 13G Large holder reported a passive stake Nov 14, 2024
- SC 13D/A Large holder reported an active stake, amended Mar 13, 2024
- SC 13D/A Large holder reported an active stake, amended Apr 27, 2023
- SC 13D/A Large holder reported an active stake, amended Jan 18, 2023
- SC 13D/A Large holder reported an active stake, amended Sep 13, 2022
Other 8 of 163
- 15-12G Feb 27, 2026
- EFFECT Notice that a registration became effective Sep 17, 2024
- CORRESP Reply to SEC staff Sep 16, 2024
- CORRESP Reply to SEC staff Sep 16, 2024
- F-1/A Registration statement, foreign issuer, amended Sep 16, 2024
- F-1/A Registration statement, foreign issuer, amended Sep 16, 2024
- UPLOAD Comment letter from SEC staff Aug 28, 2024
- EFFECT Notice that a registration became effective Jul 12, 2024
Everything here comes from Altamira Therapeutics Ltd.'s own filings on SEC EDGAR. The filing list is rechecked every hour.